HAGENS-BERMAN-securities-press-release.jpg
OASM CLASS ACTION DEADLINE: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of Upcoming Lead Plaintiff Deadline
September 10, 2019 20:08 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Oasmia Pharmaceutical AB (NASDAQ: OASM) of the September 27, 2019 lead plaintiff deadline in a federal securities...
HB Press Release Logo.jpg
OASM LITIGATION DEADLINE REMINDER: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of September 27, 2019 Lead Plaintiff Deadline
September 03, 2019 20:11 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Oasmia Pharmaceutical AB (NASDAQ: OASM) of the September 27, 2019 lead plaintiff deadline in a federal securities...
HB Press Release Logo.jpg
OASM CLASS ACTION DEADLINE: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of Upcoming Lead Plaintiff Deadline
August 28, 2019 20:07 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Oasmia Pharmaceutical AB (NASDAQ: OASM) of the September 27, 2019 lead plaintiff deadline in a federal securities...
Hagens Berman Sobol Shapiro LLP Logo
CLASS ACTION REMINDER: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of September 27, 2019 Lead Plaintiff Deadline
August 07, 2019 20:13 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Oasmia Pharmaceutical AB (NASDAQ: OASM) of the September 27, 2019 Lead Plaintiff deadline in the...
Hagens Berman Sobol Shapiro LLP Logo
OASM CLASS ACTION ALERT: Hagens Berman Alerts Investors in Oasmia Pharmaceutical AB (OASM) to Securities Fraud Class Action
July 29, 2019 20:11 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 29, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Oasmia Pharmaceutical AB (NASDAQ: OASM) to the securities class action, Mikhlin v. Oasmia...